GlobeNewswire07.16.19
Conformis Inc., a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell patient specific joint replacement implants designed to fit each patient's unique anatomy, announced a new alliance with Regent Surgical Health.
Working together, the organizations will aim to develop innovative ways to help reduce cost and improve patient outcomes relating to outpatient total joint replacement in alternative sites of care.
A privately held surgery center development and management company in the United States, Regent Surgical Health owns or operates 26 U.S. surgical facilities, 21 hospital joint ventures, 3 bundled payment entities, and 14 total joint replacement centers.
“Conformis has transformed joint replacement technology which has led to better patient outcomes,” said Chris Bishop, CEO of Regent Surgical Health. “Our collaboration builds on that and allows us to improve clinical pathways for patients while enhancing the value proposition for surgeons, employers, and payers.”
“We are pleased to collaborate with Regent Surgical Health to help bring about improved outcomes and efficiencies in outpatient total joint surgery,” said Mark Augusti, CEO of Conformis. “It is clear that payers and providers want to establish a business and clinical care model that results in better patient outcomes and enables delivery of total joint arthroplasty resulting in overall lower cost of care.”
Working together, the organizations will aim to develop innovative ways to help reduce cost and improve patient outcomes relating to outpatient total joint replacement in alternative sites of care.
A privately held surgery center development and management company in the United States, Regent Surgical Health owns or operates 26 U.S. surgical facilities, 21 hospital joint ventures, 3 bundled payment entities, and 14 total joint replacement centers.
“Conformis has transformed joint replacement technology which has led to better patient outcomes,” said Chris Bishop, CEO of Regent Surgical Health. “Our collaboration builds on that and allows us to improve clinical pathways for patients while enhancing the value proposition for surgeons, employers, and payers.”
“We are pleased to collaborate with Regent Surgical Health to help bring about improved outcomes and efficiencies in outpatient total joint surgery,” said Mark Augusti, CEO of Conformis. “It is clear that payers and providers want to establish a business and clinical care model that results in better patient outcomes and enables delivery of total joint arthroplasty resulting in overall lower cost of care.”